These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21335197)

  • 1. Predictive value of immature reticulocyte and platelet fractions in hematopoietic recovery of allograft patients.
    Gonçalo AP; Barbosa IL; Campilho F; Campos A; Mendes C
    Transplant Proc; 2011; 43(1):241-3. PubMed ID: 21335197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation.
    Zucker ML; Murphy CA; Rachel JM; Martinez GA; Abhyankar S; McGuirk JP; Reid KJ; Plapp FV
    Lab Hematol; 2006; 12(3):125-30. PubMed ID: 16950671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.
    Torres A; Sánchez J; Lakomsky D; Serrano J; Alvarez MA; Martín C; Valls C; Nevado L; Rodriguez A; Casaño J; Martínez F; Gómez P
    Haematologica; 2001 Jan; 86(1):24-9. PubMed ID: 11146566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticulocyte maturation parameters are reliable early predictors of hematopoietic engraftment after allogeneic stem cell transplantation.
    Molina JR; Sanchez-Garcia J; Torres A; Alvarez MA; Serrano J; Casaño J; Gomez P; Martinez F; Rodriguez A; Martin C
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):172-82. PubMed ID: 17241923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of immature platelet fraction and immature reticulocyte fraction as predictors of engraftment after hematopoietic stem cell transplantation.
    Morkis IV; Farias MG; Rigoni LD; Scotti L; Gregianin LJ; Daudt LE; Silla LM; Paz AA
    Int J Lab Hematol; 2015 Apr; 37(2):259-64. PubMed ID: 25066534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation.
    Briggs C; Hart D; Kunka S; Oguni S; Machin SJ
    Transfus Med; 2006 Apr; 16(2):101-9. PubMed ID: 16623916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric reticulocyte quantification in the evaluation of hematologic recovery. Spanish Multicentric Study Group for Hematopoietic Recovery.
    Eur J Haematol; 1994 Nov; 53(5):293-7. PubMed ID: 7529198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immature platelet fraction is a useful marker for predicting the timing of platelet recovery in patients with cancer after chemotherapy and hematopoietic stem cell transplantation.
    Yamaoka G; Kubota Y; Nomura T; Inage T; Arai T; Kitanaka A; Saigo K; Iseki K; Baba N; Taminato T
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e208-16. PubMed ID: 20456520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immature platelets do not reliably predict platelet recovery in patients with intensive chemotherapy or stem cell transplantation.
    Meintker L; Fritsch JD; Ringwald J; Krause SW
    Vox Sang; 2017 Feb; 112(2):132-139. PubMed ID: 28120415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients.
    Grazziutti ML; Dong L; Miceli MH; Cottler-Fox M; Krishna SG; Fassas A; van Rhee F; Barlogie BM; Anaissie EJ
    Bone Marrow Transplant; 2006 Feb; 37(4):403-9. PubMed ID: 16400338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy.
    Chaoui D; Chakroun T; Robert F; Rio B; Belhocine R; Legrand O; Salanoubat C; Lecrubier C; Casadevall N; Marie JP; Elalamy I
    Transfusion; 2005 May; 45(5):766-72. PubMed ID: 15847667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of parameters obtained from the Sysmex XN-2000 for predicting the recovery of the absolute neutrophil count and platelets after hematopoietic stem cell transplantation.
    Park SH; Park CJ; Kim MJ; Han MY; Lee BR; Cho YU; Jang S; Kwon SW; Kim DY; Lee JH; Lee JH; Lee KH
    Int J Lab Hematol; 2016 Apr; 38(2):198-208. PubMed ID: 26834006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated reticulocyte response is a good predictor of bone-marrow recovery in pediatric malignancies.
    Das R; Rawal A; Garewal G; Marwaha RK; Vohra H
    Pediatr Hematol Oncol; 2006 Jun; 23(4):299-305. PubMed ID: 16621771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant.
    Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ
    Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed platelet engraftment in group O patients after autologous progenitor cell transplantation.
    Hoffmann S; Zhou L; Gu Y; Davenport R; Cooling L
    Transfusion; 2005 Jun; 45(6):885-95. PubMed ID: 15934986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation.
    Takami A; Shibayama M; Orito M; Omote M; Okumura H; Yamashita T; Shimadoi S; Yoshida T; Nakao S; Asakura H
    Bone Marrow Transplant; 2007 Apr; 39(8):501-7. PubMed ID: 17334382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation.
    Cornelissen JJ; Fibbe WE; Schattenberg AV; Petersen EJ; Willemze R; de Witte TJ; Löwenberg B; Verdonck LF; vd Biezen A; Brand R
    Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S66-70. PubMed ID: 9712499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34+ megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant.
    Maharaj D; Steinberg JP; Gouvea JV; Gieser PW
    Bone Marrow Transplant; 1999 Mar; 23(6):539-48. PubMed ID: 10217183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.